261 related articles for article (PubMed ID: 25643871)
1. Triazole: A Promising Antitubercular Agent.
Keri RS; Patil SA; Budagumpi S; Nagaraja BM
Chem Biol Drug Des; 2015 Oct; 86(4):410-23. PubMed ID: 25643871
[TBL] [Abstract][Full Text] [Related]
2. Quinoline: a promising antitubercular target.
Keri RS; Patil SA
Biomed Pharmacother; 2014 Oct; 68(8):1161-75. PubMed ID: 25458785
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
4. New insights into chemistry and anti-infective potential of triazole scaffold.
Kharb R; Yar MS; Sharma PC
Curr Med Chem; 2011; 18(21):3265-97. PubMed ID: 21671862
[TBL] [Abstract][Full Text] [Related]
5. Recent progress on pyrazole scaffold-based antimycobacterial agents.
Keri RS; Chand K; Ramakrishnappa T; Nagaraja BM
Arch Pharm (Weinheim); 2015 May; 348(5):299-314. PubMed ID: 25820461
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
8. Triazole derivatives and their anti-tubercular activity.
Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
[TBL] [Abstract][Full Text] [Related]
9. Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents.
Cao Y; Lu H
Future Med Chem; 2021 Dec; 13(23):2107-2124. PubMed ID: 34698509
[TBL] [Abstract][Full Text] [Related]
10. Triazole-containing hybrids with anti-
Tan Z; Deng J; Ye Q; Zhang Z
Future Med Chem; 2021 Apr; 13(7):643-662. PubMed ID: 33619989
[TBL] [Abstract][Full Text] [Related]
11. Recent researches in triazole compounds as medicinal drugs.
Zhou CH; Wang Y
Curr Med Chem; 2012; 19(2):239-80. PubMed ID: 22320301
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological significance of triazole scaffold.
Kharb R; Sharma PC; Yar MS
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):1-21. PubMed ID: 20583859
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the research of heterocyclic compounds as antitubercular agents.
Yan M; Ma S
ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
[TBL] [Abstract][Full Text] [Related]
16. Emerging impact of triazoles as anti-tubercular agent.
Sharma A; Agrahari AK; Rajkhowa S; Tiwari VK
Eur J Med Chem; 2022 Aug; 238():114454. PubMed ID: 35597009
[TBL] [Abstract][Full Text] [Related]
17. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
18. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
20. Antituberculosis drugs: ten years of research.
Janin YL
Bioorg Med Chem; 2007 Apr; 15(7):2479-513. PubMed ID: 17291770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
